Reuters logo
Slovenian drug firm Krka's Q1 net profit rises 29.5 pct
May 14, 2015 / 10:17 AM / 2 years ago

Slovenian drug firm Krka's Q1 net profit rises 29.5 pct

LJUBLJANA, May 14 (Reuters) - Slovenian pharmaceutical company Krka posted a 29.5 percent rise in first-quarter net profit to 55.1 million euros, the company said on Thursday.

Sales fell to 289.3 million euros in the January-March period, from 298 million in the same quarter of 2014, it said.

Reporting By Marja Novak; Editing by Pravin Char

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below